Bright U, Akirav I
Cells. 2025; 14(2).
PMID: 39851527
PMC: 11763596.
DOI: 10.3390/cells14020099.
Portugalov A, Peled G, Zorin S, Akirav I
Biomolecules. 2024; 14(11).
PMID: 39595561
PMC: 11591736.
DOI: 10.3390/biom14111384.
McCartney D, Irwin C, Bawa Z, Palmer B, Sahinovic A, Delang N
Sports Med Open. 2024; 10(1):61.
PMID: 38782848
PMC: 11116295.
DOI: 10.1186/s40798-024-00727-3.
Rosado-Franco J, Ellison A, White C, Price A, Moore C, Williams R
Physiol Rep. 2024; 12(4):e15947.
PMID: 38408761
PMC: 10896677.
DOI: 10.14814/phy2.15947.
Pinto J, Crippa J, Cereser K, Vianna-Sulzbach M, Silveira Junior E, Santana da Rosa G
Can J Psychiatry. 2023; 69(4):242-251.
PMID: 37920963
PMC: 10924581.
DOI: 10.1177/07067437231209650.
Cannabidiol Modulates Emotional Function and Brain-Derived Neurotrophic Factor Expression in Middle-Aged Female Rats Exposed to Social Isolation.
Saad N, Raviv D, Mizrachi Zer-Aviv T, Akirav I
Int J Mol Sci. 2023; 24(20).
PMID: 37895171
PMC: 10607116.
DOI: 10.3390/ijms242015492.
Sex-Dependent Synergism of an Edible THC: CBD Formulation in Reducing Anxiety and Depressive-like Symptoms Following Chronic Stress.
Perez-Valenzuela E, Hudson R, Uzuneser T, De Felice M, Szkudlarek H, Rushlow W
Curr Neuropharmacol. 2023; 22(12):2059-2078.
PMID: 37702237
PMC: 11333796.
DOI: 10.2174/1570159X21666230912101441.
Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies.
Luz-Veiga M, Azevedo-Silva J, Fernandes J
Pharmaceuticals (Basel). 2023; 16(2).
PMID: 37259306
PMC: 9958812.
DOI: 10.3390/ph16020155.
Cannabinoid Receptor 2 Blockade Prevents Anti-Depressive-like Effect of Cannabidiol Acid Methyl Ester in Female WKY Rats.
Hen-Shoval D, Moshe L, Indig-Naimer T, Mechoulam R, Shoval G, Zalsman G
Int J Mol Sci. 2023; 24(4).
PMID: 36835237
PMC: 9958868.
DOI: 10.3390/ijms24043828.
Cannabidiol Modulates Alterations in PFC microRNAs in a Rat Model of Depression.
Bright U, Akirav I
Int J Mol Sci. 2023; 24(3).
PMID: 36768376
PMC: 9953518.
DOI: 10.3390/ijms24032052.
Sex Differences in the Neuropsychiatric Effects and Pharmacokinetics of Cannabidiol: A Scoping Review.
Matheson J, Bourgault Z, Le Foll B
Biomolecules. 2022; 12(10).
PMID: 36291671
PMC: 9599539.
DOI: 10.3390/biom12101462.
Hemp in Animal Diets-Cannabidiol.
Fallahi S, Bobak L, Opalinski S
Animals (Basel). 2022; 12(19).
PMID: 36230282
PMC: 9559627.
DOI: 10.3390/ani12192541.
Review: Cannabinoids as Medicinals.
Khalsa J, Bunt G, Blum K, Maggirwar S, Galanter M, Potenza M
Curr Addict Rep. 2022; 9(4):630-646.
PMID: 36093358
PMC: 9449267.
DOI: 10.1007/s40429-022-00438-3.
Cannabidiol Reduces Short- and Long-Term High Glutamate Release after Severe Traumatic Brain Injury and Improves Functional Recovery.
Santiago-Castaneda C, Huerta de la Cruz S, Martinez-Aguirre C, Orozco-Suarez S, Rocha L
Pharmaceutics. 2022; 14(8).
PMID: 36015236
PMC: 9414526.
DOI: 10.3390/pharmaceutics14081609.
Dose-Dependent Antidepressant-Like Effects of Cannabidiol in Aged Rats.
Hernandez-Hernandez E, Garcia-Fuster M
Front Pharmacol. 2022; 13:891842.
PMID: 35847003
PMC: 9283859.
DOI: 10.3389/fphar.2022.891842.
Exploring pharmacological options for adolescent depression: a preclinical evaluation with a sex perspective.
Ledesma-Corvi S, Hernandez-Hernandez E, Garcia-Fuster M
Transl Psychiatry. 2022; 12(1):220.
PMID: 35650182
PMC: 9160287.
DOI: 10.1038/s41398-022-01994-y.
Modulation of Endocannabinoid System Components in Depression: Pre-Clinical and Clinical Evidence.
Bright U, Akirav I
Int J Mol Sci. 2022; 23(10).
PMID: 35628337
PMC: 9146799.
DOI: 10.3390/ijms23105526.
Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice.
Austrich-Olivares A, Garcia-Gutierrez M, Illescas L, Gasparyan A, Manzanares J
Pharmaceuticals (Basel). 2022; 15(4).
PMID: 35455470
PMC: 9027088.
DOI: 10.3390/ph15040473.
The NLRP3 Inflammasome in Stress Response: Another Target for the Promiscuous Cannabidiol.
Hartmann A, Vila-Verde C, Guimaraes F, Joca S, Lisboa S
Curr Neuropharmacol. 2022; 21(2):284-308.
PMID: 35410608
PMC: 10190150.
DOI: 10.2174/1570159X20666220411101217.
Examining the Use of Antidepressants for Adolescents with Depression/Anxiety Who Regularly Use Cannabis: A Narrative Review.
Hen-Shoval D, Weller A, Weizman A, Shoval G
Int J Environ Res Public Health. 2022; 19(1).
PMID: 35010782
PMC: 8744706.
DOI: 10.3390/ijerph19010523.